Fgf10 is an oncogene activated by MMTV insertional mutagenesis in mouse mammary tumors and overexpressed in a subset of human breast carcinomas
about
Mouse mammary tumor virus integration site selection in human and mouse genomesPresence of mouse mammary tumour-like virus gene sequences may be associated with morphology of specific human breast cancerA genome-wide association study of breast and prostate cancer in the NHLBI's Framingham Heart StudySeven prostate cancer susceptibility loci identified by a multi-stage genome-wide association studySystematic analysis of secreted proteins reveals synergism between IL6 and other proteins in soft agar growth of MCF10A cellsSignalling pathways implicated in early mammary gland morphogenesis and breast cancer.Allele-specific up-regulation of FGFR2 increases susceptibility to breast cancer.Mammary gland growth factors: roles in normal development and in cancer.Mouse mammary tumor virus molecular biology and oncogenesisConfirmation of 5p12 as a susceptibility locus for progesterone-receptor-positive, lower grade breast cancerThe Fibroblast Growth Factor signaling pathwayAnalysis of tumor heterogeneity and cancer gene networks using deep sequencing of MMTV-induced mouse mammary tumors.CCAAT/enhancer-binding protein beta: its role in breast cancer and associations with receptor tyrosine kinases.Common integration sites for MMTV in viral induced mouse mammary tumors.Genetic variants in the MRPS30 region and postmenopausal breast cancer riskAllele-specific regulation of FGFR2 expression is cell type-dependent and may increase breast cancer risk through a paracrine stimulus involving FGF10Human RNA "rumor" viruses: the search for novel human retroviruses in chronic diseaseCombinatorial targeting of FGF and ErbB receptors blocks growth and metastatic spread of breast cancer models.Polygenic susceptibility to breast cancer: current state-of-the-art.Resident cellular components of the lung: developmental aspects.Negative regulation of fibroblast growth factor 10 (FGF-10) by polyoma enhancer activator 3 (PEA3).Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation.Fibroblast growth factors and their receptors in cancer.Pleiotropic functions of fibroblast growth factor signaling in embryonic mammary gland development.Fibroblast growth factor 10 upregulates the expression of mucins in rat conjunctival epithelial cells.Translating genetic risk factors for prostate cancer to the clinic: 2013 and beyond.Induction of fibroblast growth factor 10 (FGF10) in the ileal crypt epithelium after massive small bowel resection suggests a role for FGF10 in gut adaptation.MMTV insertional mutagenesis identifies genes, gene families and pathways involved in mammary cancer.Recent translational research: oncogene discovery by insertional mutagenesis gets a new boost.Exogenous FGF10 can rescue an eye-open at birth phenotype of Fgf10-null mice by activating activin and TGFalpha-EGFR signaling.Common variants on chromosome 5p12 confer susceptibility to estrogen receptor–positive breast cancerEmerging Roles of Fibroblast Growth Factor 10 in CancerRegulation of FGF10 Signaling in Development and Disease
P2860
Q24657146-295D37AD-FFB6-4BBF-826F-C374BAE3AB0AQ24676303-C0318CCA-84E2-4E7F-9179-31BEB2D81103Q28943278-24367981-90CE-4594-9609-F0C571A978E8Q29417074-044F9581-7411-47F7-A326-87012753B005Q31021549-7F6F7ED1-7D39-43EE-93CE-F6627647EE51Q33255332-32A0FB64-22B3-4656-8A50-EC425B4A926CQ33332300-91B34E54-A6A0-48EF-B89A-51A4CCF876C0Q34014659-D89AADAA-69B5-4640-9E2F-54941C56F678Q34161161-55B19EE1-C258-4A75-BD97-7649AC93BFBFQ34181322-286A27C3-F9F3-495E-85B6-A5866AC8FB64Q34467171-E02E473E-483C-4CB8-9178-EC59C40255A2Q34729803-DF3CFECF-C702-4385-ABD9-F71B885B44C0Q34983912-2F008CF4-ED7B-4456-9109-2BB6982045B1Q35014892-AD73C03C-090A-428F-B85D-93B8D8F8B311Q35557640-BA84F67B-9891-4177-BF0B-9A06EC1234EEQ35608687-E5A13F5F-9F7A-42FD-B9B2-322E7FFB0CB1Q36497719-9F1594B6-F8A4-474C-AF6A-11558CF862B9Q36903398-FC131EDB-F35A-4DBB-8220-00ACFB02677CQ37062641-F7A23667-B0FE-4FBA-9BB9-4E69BCEE5FFBQ37103571-208ADA4D-3B1F-4407-ADF5-7A140D16AC1CQ37215604-279C545D-B53C-4A3B-813D-46BA6BFDB259Q37342144-C0D24FA0-FAB3-4612-B9A4-52E2985F65DDQ37895306-836C709E-BDCF-49C3-850E-6F4565E666BEQ38101276-B2587504-26D5-4F47-B7FC-54CC6CD9CCFCQ38961889-CB24EAA0-F07A-4E4D-A0A9-657D7D8B071DQ39141778-D60F6B5C-A386-444D-8A0D-EC7C342CD479Q39942919-ED7508A3-DBB0-42DB-B7EA-FE8AB37F58DDQ40139233-4126B78B-F845-4DDD-8A88-644EF5CE1800Q43251255-21262189-B0CF-4195-B64C-66601A557822Q51185489-785F54D9-2A94-43CC-93F3-7612C1A9CEF7Q57251792-4BD8B11F-6519-4390-9009-7FBDB79B3383Q58566489-893B2377-602A-4FAF-8BE9-A1B31A090511Q58572262-54217EDA-AB67-4C75-9C90-D45E0EF93CF5
P2860
Fgf10 is an oncogene activated by MMTV insertional mutagenesis in mouse mammary tumors and overexpressed in a subset of human breast carcinomas
description
2004 nî lūn-bûn
@nan
2004 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Fgf10 is an oncogene activated ...... set of human breast carcinomas
@ast
Fgf10 is an oncogene activated ...... set of human breast carcinomas
@en
Fgf10 is an oncogene activated ...... set of human breast carcinomas
@nl
type
label
Fgf10 is an oncogene activated ...... set of human breast carcinomas
@ast
Fgf10 is an oncogene activated ...... set of human breast carcinomas
@en
Fgf10 is an oncogene activated ...... set of human breast carcinomas
@nl
prefLabel
Fgf10 is an oncogene activated ...... set of human breast carcinomas
@ast
Fgf10 is an oncogene activated ...... set of human breast carcinomas
@en
Fgf10 is an oncogene activated ...... set of human breast carcinomas
@nl
P2093
P2860
P356
P1433
P1476
Fgf10 is an oncogene activated ...... set of human breast carcinomas
@en
P2093
Britta Weigelt
Jos Jonkers
Mandy Boer
Martin van der Valk
P2860
P2888
P304
P356
10.1038/SJ.ONC.1207816
P407
P577
2004-08-01T00:00:00Z
P5875
P6179
1022337175